Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...

Mayo Clinic clinicians are starting to explore how they might use healthcare-specific large language models – accessed through a generative artificial intelligence chat application – to enhance ...

Tocilizumab is effective and safe for rheumatoid arthritis, with long-term studies supporting its use and comparable cardiovascular risk to tumor necrosis factor inhibitors. Real-world data indicate ...

Ruxolitinib demonstrated sustained efficacy and improved quality of life in myelofibrosis patients in a real-world setting. The JAKoMo study reported fewer adverse events than clinical trials, ...

Sacituzumab govitecan (SG) is approved for the treatment of metastatic triple-negative breast cancer (mTNBC). We report the real-world clinical effectiveness and toxicity data of SG in patients with ...

The clinical trials arena is becoming increasingly data-driven, with demand growing for sponsors to have real-time data access and ongoing updates throughout a study rather than just a final report.

The integration of real-world data (RWD) into protocol feasibility and site selection has emerged as a clinical trial game-changer in recent years. Traditionally relying heavily on data from carefully ...

Application developers and solution partners often need to process healthcare data outside of the electronic medical record (EMR) system. EMRs are primarily designed to directly support individual ...